|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 43/58 |
| (11) | Number of the document | 3243385 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17173914.7 |
| Date of filing the European patent application | 2012-02-23 | |
| (97) | Date of publication of the European application | 2017-11-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161446551 P | 2011-02-25 | US |
| (72) |
ANAND, Rajan, US
APGAR, James, M., US
BIFTU, Tesfaye, US
CHEN, Ping, US
CHU, Lin, US
COLANDREA, Vincent, J., US
DONG, Guizhen, US
DROPINSKI, James, F., US
FENG, Danqing, US
HICKS, Jacqueline, D., US
JIANG, Jinlong, US
KIM, Alexander, J., US
LEAVITT, Kenneth, J., US
LI, Bing, US
QIAN, Xiaoxia, US
SEBHAT, Iyassu, US
WEI, Lan, US
WILKENING, Robert, R., US
WU, Zhicai, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS |
| NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS |